Private Trust Co. NA Has $385,000 Position in The Clorox Company (NYSE:CLX)

Private Trust Co. NA cut its position in The Clorox Company (NYSE:CLXFree Report) by 5.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,362 shares of the company’s stock after selling 144 shares during the period. Private Trust Co. NA’s holdings in Clorox were worth $385,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Diversified LLC bought a new position in Clorox during the third quarter worth about $237,000. Mirabella Financial Services LLP raised its position in shares of Clorox by 1.9% during the third quarter. Mirabella Financial Services LLP now owns 8,790 shares of the company’s stock worth $1,432,000 after purchasing an additional 164 shares during the period. Daiwa Securities Group Inc. lifted its holdings in shares of Clorox by 2.9% during the 3rd quarter. Daiwa Securities Group Inc. now owns 15,240 shares of the company’s stock valued at $2,483,000 after purchasing an additional 426 shares in the last quarter. Summit Trail Advisors LLC grew its position in shares of Clorox by 2.3% in the 3rd quarter. Summit Trail Advisors LLC now owns 9,480 shares of the company’s stock valued at $1,544,000 after purchasing an additional 213 shares during the period. Finally, Cerity Partners LLC increased its stake in Clorox by 13.5% during the 3rd quarter. Cerity Partners LLC now owns 52,454 shares of the company’s stock worth $8,545,000 after purchasing an additional 6,232 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and lifted their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. BNP Paribas upgraded Clorox to a “strong sell” rating in a report on Friday, September 6th. Barclays increased their price objective on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Finally, DA Davidson upped their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $155.00.

Check Out Our Latest Stock Report on Clorox

Clorox Stock Performance

NYSE CLX opened at $167.16 on Thursday. The firm has a market capitalization of $20.69 billion, a P/E ratio of 58.24, a price-to-earnings-growth ratio of 3.07 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm’s fifty day moving average price is $162.91 and its two-hundred day moving average price is $149.01. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.35.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s revenue was up 27.0% on a year-over-year basis. During the same period last year, the business posted $0.49 EPS. As a group, research analysts anticipate that The Clorox Company will post 6.85 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.92%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is presently 170.04%.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.57% of the stock is owned by company insiders.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.